The global demand for Healthcare Contract Development And Manufacturing Organization Market is presumed to reach the market size of nearly USD 626.83 MN by 2028 from USD 317.6 MN in 2021 with a CAGR of 10.2% under the study period 2022 - 2028.
Contract development and manufacturing organization (CDMO), sometimes known as a contract manufacturing organization (CMO), is a corporation that provides entire drug development and manufacturing services to other pharmaceutical companies on a contract basis. CDMO allows major pharmaceutical companies to outsource those business portions, focusing on medication discovery and marketing instead. CDMOS offers various services, including pre-formulation, formulation development, stability research, method development, materials for pre-clinical and Phase I clinical trials, late-stage clinical trials, scale-up, formal stability, registration batches, and commercial manufacture. CDMOS arose due to the highly competitive international character of the pharmaceutical industry and the growing need for outsourced services.
Market Dynamics
An increase in pharmaceutical companies' usage of outsourcing services and rising R&D spending are projected to drive the market. The presence of end-to-end service providers who provide value-added services for an integrated or risk-sharing business model will likely promote market expansion. Furthermore, since pharmaceutical and medical device companies face increasing pressure to fulfil tight deadlines, the demand for outsourcing research and manufacturing to CDMOs has increased. In addition, the increased demand for early-stage development CDMOs is likely to be fueled by an increase in R&D outsourcing and CDMO competencies. Low-end services are being outsourced by medical device and pharmaceutical businesses to save total production costs. This tendency is expected to support the expansion of the healthcare contract development and manufacturing organization (CDMO) market during the projected period.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of healthcare contract development and manufacturing organization. The growth and trends of healthcare contract development and manufacturing organization industry provide a holistic approach to this study.
Market Segmentation
This section of the healthcare contract development and manufacturing organization market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Service
- Contract Development
- Contract Manufacturing
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Healthcare Contract Development And Manufacturing Organization market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Healthcare Contract Development And Manufacturing Organization Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the healthcare contract development and manufacturing organization market include Catalent Inc., Lonza Group Ltd., Recipharm AB, Siegfried Holding AG, Thermo Fisher Scientific Inc., Covance Inc., Jabil, Sanmina Corporation, IQVIA Holdings Inc., Flex, AbbVie Inc., Baxter International, Inc., Pfizer Inc., and Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.